Cell Therapy News/Articles, page-320

  1. 2,117 Posts.
    lightbulb Created with Sketch. 742
    Exactly, I bought more this week.  Never though I would get the opportunity to buy down this low below $1.40 again once it was up over $2 last year, so taking full advantage of this...will keep buying as much as possible while under $2.

    Interesting to compare MSB to CUV...MSB is way undervalue for where they are and what they have in the pipeline in comparison.  CUV Market Cap currently twice that of MSB and pretty much just one treatment being pursued in different ways. CUV in Phase 3 with that one treatment and some starting sales and FDA submission at same time and MSB. 

    Hmm manipulation much on MSB...is comical really.

    Anyway, I will just keep buying.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.83
Change
-0.035(1.88%)
Mkt cap ! $2.331B
Open High Low Value Volume
$1.88 $1.94 $1.82 $11.55M 6.216M

Buyers (Bids)

No. Vol. Price($)
2 40245 $1.83
 

Sellers (Offers)

Price($) Vol. No.
$1.84 25000 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.